Anemia in diabetes: marker or mediator of microvascular disease? (Q36689806)

15 August 2017

1 reference

title

Anemia in diabetes: marker or mediator of microvascular disease? (English)

1 reference

15 August 2017

0 references

Merlin C Thomas

1

1 reference

15 August 2017

1 January 2007

1 reference

Nature Clinical Practice Nephrology

15 August 2017

1 reference

15 August 2017

3

1 reference

15 August 2017

1

1 reference

15 August 2017

20-30

1 reference

Diastolic dysfunction is associated with anaemia in patients with Type II diabetes

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

Reversible hematologic sequelae of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

The prevalence of anemia in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Unrecognized anemia in patients with diabetes: a cross-sectional survey

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Evidence-based systematic literature review of hemoglobin/hematocrit and all-cause mortality in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Clinical characteristics of chronic kidney disease patients with and without diabetes: a subanalysis of the PAERI study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Anemia with erythropoietin deficiency occurs early in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

The epidemiology of hemoglobin levels in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Anemia in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Anemia and diabetes in the absence of nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Normocytic normochromic anemia due to automatic neuropathy in type 2 diabetic patients without severe nephropathy: a possible role of microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Anaemia in diabetes: an emerging complication of microvascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Anemia with impaired erythropoietin response in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Proximal tubular basement membrane width in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Tubular changes in early diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Reactive oxygen species and molecular regulation of renal oxygenation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Erythropoietin depletion and anaemia in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Abnormal membrane fluidity and acetylcholinesterase activity in erythrocytes from insulin-dependent diabetic patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Membrane lipid alterations and Na+-pumping activity in erythrocytes from IDDM and NIDDM subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects on filterability and implications for microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Effect of vitamin E and N-acetylcysteine on phosphatidylserine externalization and induction of coagulation by high-glucose-treated human erythrocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

In vitro effects of high glucose concentrations on membrane protein oxidation, G-actin and deformability of human erythrocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Increased urinary haemoglobin in diabetics with microalbuminuria--measured by an ELISA

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Altered red cell turnover in diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Soluble transferrin receptor level: a new marker of iron deficiency anemia, a common manifestation of gastric autoimmunity in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Emerging concepts in celiac disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Elevated iron indices in patients with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Cross-talk between iron metabolism and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

How should we manage anaemia in patients with diabetes?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Progression of nephropathy in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Anaemia in diabetes: Is there a rationale to TREAT?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Anemia and new-onset congestive heart failure in the general Medicare population

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Relation of anemia to diastolic heart failure and the effect on outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Impact of diabetes on cardiac structure and function: the strong heart study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Cerebral blood flow and vasodilatory capacity in anemia secondary to chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Is endogenous erythropoietin a pathogenetic factor in the development of essential hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Erythropoietin impairs endothelium-dependent vasorelaxation through cyclooxygenase-dependent mechanisms in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Nonhematologic complications of erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

The relationship between hemoglobin levels and diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Erythropoietin in diabetic macular edema and renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

The impact of reversal of hypoxia by revascularization on the peripheral nerve function of diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Erythropoietin both protects from and reverses experimental diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Incidence of cutaneous vasoactivity in patients with anemia and pulmonary hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Institutionalization following diabetes-related lower extremity amputation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Is erythropoietin the key to optimize wound healing?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0378

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0378

1 reference

15 August 2017

1 reference

PubMed ID

17183259